Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-08-10 Purchase | 2026-08-10 8:21 pm | Latigo Biotherapeutics Inc. | LTGO | Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Management VI LLC Foresite Capital Fund VI LP 10% Owner | 140,000 | $18 | $2,520,000 | 3,414,544 (Indirect) | View |
| 2026-08-10 Purchase | 2026-08-10 8:00 pm | Latigo Biotherapeutics Inc. | LTGO | Tananbaum James B. Director 10% Owner | 140,000 | $18 | $2,520,000 | 3,414,544 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-08-10 Conversion | 2026-08-12 4:13 pm | N/A N/A | Latigo Biotherapeutics Inc. | LTGO | 5AM Ventures VI L.P. 5AM Partners VI LLC 5AM Opportunities II L.P. 5AM Opportunities II (GP) LLC PARMAR KUSH Schwab Andrew J. 10% Owner | 14,651,924 | $0 | 2,350,419 (Indirect) | View |
| 2026-08-10 Conversion | 2026-08-12 08:18 am | N/A N/A | Latigo Biotherapeutics Inc. | LTGO | Sanofi 10% Owner | 672,778 | $0 | 672,788 (Indirect) | View |
Ownership | 2026-08-12 08:09 am | N/A N/A | Latigo Biotherapeutics Inc. | LTGO | Sanofi 10% Owner | 0 | $0 | 672,778 (Indirect) | View |
| 2026-08-10 Conversion | 2026-08-11 06:00 am | N/A N/A | Latigo Biotherapeutics Inc. | LTGO | Westlake BioPartners Fund I L.P. Westlake BioPartners GP I LLC Westlake BioPartners Fund II L.P. Westlake BioPartners GP II LLC Westlake BioPartners Opportunity Fund I L.P. Westlake BioPartners Opportunity GP I LLC 10% Owner | 12,695,305 | $0 | 2,094,813 (Indirect) | View |
| 2026-08-10 Conversion | 2026-08-10 8:21 pm | N/A N/A | Latigo Biotherapeutics Inc. | LTGO | Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Management VI LLC Foresite Capital Fund VI LP 10% Owner | 9,041,328 | $0 | 3,414,544 (Indirect) | View |
| 2026-08-06 Option Award | 2026-08-10 8:00 pm | N/A 2036-08-05 | Latigo Biotherapeutics Inc. | LTGO | SMITH TODD N Director | 105,542 | $0 | 105,542 (Direct) | View |
| 2026-08-10 Conversion | 2026-08-10 8:00 pm | N/A N/A | Latigo Biotherapeutics Inc. | LTGO | Tananbaum James B. Director 10% Owner | 9,041,328 | $0 | 3,414,544 (Indirect) | View |
| 2026-08-10 Conversion | 2026-08-10 8:00 pm | N/A N/A | Latigo Biotherapeutics Inc. | LTGO | SEIDENBERG BETH C Director 10% Owner | 12,695,305 | $0 | 2,094,813 (Indirect) | View |
Ownership | 2026-08-06 9:38 pm | N/A N/A | Latigo Biotherapeutics Inc. | LTGO | Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Fund VI LP Foresite Capital Management VI LLC 10% Owner | 0 | $0 | 9,041,328 (Indirect) | View |
Ownership | 2026-08-06 8:52 pm | N/A N/A | Latigo Biotherapeutics Inc. | LTGO | 5AM Ventures VI L.P. 5AM Partners VI LLC 5AM Opportunities II L.P. 5AM Opportunities II (GP) LLC PARMAR KUSH Schwab Andrew J. 10% Owner | 0 | $0 | 7,325,962 (Indirect) | View |
Ownership | 2026-08-06 8:51 pm | N/A N/A | Latigo Biotherapeutics Inc. | LTGO | Westlake BioPartners Fund I L.P. Westlake BioPartners GP I LLC Westlake BioPartners Fund II L.P. Westlake BioPartners GP II LLC Westlake BioPartners Opportunity Fund I L.P. Westlake BioPartners Opportunity GP I LLC 10% Owner | 0 | $0 | 13,199,669 (Indirect) | View |
Ownership | 2026-08-06 8:33 pm | N/A 2034-10-29 | Latigo Biotherapeutics Inc. | LTGO | Walbert Timothy P Director | 0 | $0 | 329,819 (Direct) | View |
Ownership | 2026-08-06 8:33 pm | N/A 2035-04-07 | Latigo Biotherapeutics Inc. | LTGO | Krishnamohan Neha CFO and Chief Business Officer | 0 | $0 | 686,026 (Direct) | View |
Ownership | 2026-08-06 8:32 pm | N/A 2036-04-06 | Latigo Biotherapeutics Inc. | LTGO | Bonstein Sara Director | 0 | $0 | 105,542 (Direct) | View |
Ownership | 2026-08-06 8:31 pm | N/A 2034-07-30 | Latigo Biotherapeutics Inc. | LTGO | Singla Neil Chief Medical Officer | 0 | $0 | 1,055,425 (Direct) | View |
Ownership | 2026-08-06 8:31 pm | N/A N/A | Latigo Biotherapeutics Inc. | LTGO | Farzan Nima President and CEO | 0 | $0 | 2,902,419 (Indirect) | View |
Ownership | 2026-08-06 8:30 pm | N/A N/A | Latigo Biotherapeutics Inc. | LTGO | Tananbaum James B. Director 10% Owner | 0 | $0 | 9,041,328 (Indirect) | View |
Ownership | 2026-08-06 8:30 pm | N/A N/A | Latigo Biotherapeutics Inc. | LTGO | SEIDENBERG BETH C Director 10% Owner | 0 | $0 | 13,199,669 (Indirect) | View |